Comparison of Immediate and Sequential Withdrawal of a Systemic Glucocorticoid in the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Multicenter, Randomized, Double-Blind, Parallel-Controlled, Open-Label Study

Comparison of Immediate and Sequential Withdrawal of a Systemic Glucocorticoid in the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Multicenter, Randomized, Double-Blind, Parallel-Controlled, Open-Label Study

Patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD) were treated with immediate or sequential withdrawal after 5 days of systemic glucocorticoids. The effects of the two withdrawal methods on the prognosis of patients were compared at 30, 90, 180, and 360 days after d...

Full description

Bibliographic Details
Main Authors:	Ling Zhou, Yuanyuan Fang, Wei Liu, Jianchu Zhang, Yingnan Wang, Sheng Xie, Minhua Zhong, Zhengyan Wang, Guangcai Li, Hongyan Ai, Hongrong Guo, Fanjun Zeng, Wei Xiao, Chenghong Li, Yi Hu, Yijun Tang, Huiguo Liu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-05-01
Series:	Frontiers in Molecular Biosciences
Subjects:	glucocorticoids immediately withdrawal sequential withdrawal acute exacerbations of chronic obstructive pulmonary disease prognosis methyl predrone
Online Access:	https://www.frontiersin.org/articles/10.3389/fmolb.2021.639079/full

Similar Items

Glucocorticoid Withdrawal in Lupus Nephritis: A Study Protocol and Literature Review
by: Natalia Chu Oi Ciang, et al.
Published: (2020-12-01)

Glucocorticoid Withdrawal—An Overview on When and How to Diagnose Adrenal Insufficiency in Clinical Practice
by: Katarzyna Pelewicz, et al.
Published: (2021-04-01)

Targeting the Glucocorticoid Receptors During Alcohol Withdrawal to Reduce Protracted Neurocognitive Disorders
by: Daniel Béracochéa, et al.
Published: (2019-09-01)

Opioid withdrawal presenting as delirium and role of buprenorphine: A case series
by: Sourav Das, et al.
Published: (2017-01-01)

Overuse of inhaled corticosteroids in COPD: five questions for withdrawal in daily practice
by: Cataldo D, et al.
Published: (2018-07-01)

Challenges in the postsurgical recovery of cushing syndrome: glucocorticoid withdrawal syndrome
by: Catherine D. Zhang, et al.
Published: (2024-04-01)

Morphine Withdrawal Enhances HIV Infection of Macrophages
by: Xu Wang, et al.
Published: (2019-11-01)

Uso de glucocorticoides sistémicos para el tratamiento del asma grave: Consenso multidisciplinar español
by: Javier Domínguez-Ortega, et al.
Published: (2022-10-01)

Ethanol Infusion for Alcohol Withdrawal Prophylaxis Does Not Cause Intoxication
by: Robert Dillard, et al.
Published: (2016-10-01)

CONSIDERATIONS REGARDING THE RIGHT TO WITHDRAW OF THE STAKEHOLDERS IN THE CASE OF FUSION OF SOCIETIES. COMPARATIVE PRESENTATION
by: Silvia Lucia Cristea, et al.
Published: (2019-05-01)

Clinical and Economic Impact of Long-Term Inhaled Corticosteroid Withdrawal in Patients with Chronic Obstructive Pulmonary Disease Treated with Triple Therapy in Spain
by: Neches García V, et al.
Published: (2022-09-01)

Is Clonidine Useful for the Management of Tramadol-induced Withdrawal Syndrome?
by: Mohammad Majidi, et al.
Published: (2022-06-01)

Sex difference in alcohol withdrawal syndrome: a scoping review of clinical studies
by: Hayrunnisa Unlu, et al.
Published: (2023-09-01)

Unintentionally Trapped by Debt Review: Procedural Inadequacies in the National Credit Act 34 of 2005 Relating to Withdrawal from the Debt Review Process
by: Hermie Coetzee, et al.
Published: (2019-12-01)

Effects of Methamphetamine Withdrawal on the Volume and pH of Stimulated Saliva
by: Haleh Zokaee, et al.
Published: (2022-06-01)

First-episode psychosis induced by pregabalin withdrawal: a case report
by: İbrahim Gundogmus, et al.
Published: (2018-10-01)

Neural mechanisms underlying morphine withdrawal in addicted patients: a review
by: Nima Babhadiashar, et al.
Published: (2015-07-01)

Zolpidem dependence with withdrawal seizures
by: M Suresh Babu, et al.
Published: (2023-01-01)

The nature and impact of antidepressant withdrawal symptoms and proposal of the Discriminatory Antidepressant Withdrawal Symptoms Scale (DAWSS)
by: Joanna Moncrieff, et al.
Published: (2024-04-01)

Baclofen Withdrawal
by: Elaine Fielder, et al.
Published: (2014-11-01)

Withdrawal of treatment in a pediatric intensive care unit at a Children’s Hospital in China: a 10-year retrospective study
by: Huaqing Liu, et al.
Published: (2020-08-01)

Malignant catatonia due to clozapine withdrawal: A case report and a brief review of the literature
by: C. Regueiro Martín-Albo, et al.
Published: (2022-06-01)

Ropivacaine withdrawal syndrome: a case report
by: Dmitriy Viderman, et al.
Published: (2020-07-01)

Precipitated withdrawal with kratom use following naltrexone administration
by: Jarka Courtney PharmD, BCPS, BCPP, et al.
Published: (2023-06-01)

Effects of Opioid Withdrawal on Psychobiology in People Living with HIV
by: Igor Grant, et al.
Published: (2024-01-01)

Tramadole withdrawal in a neonate: a case report
by: Borna H, et al.
Published: (2012-09-01)

Clinical management of alcohol withdrawal: A systematic review
by: Shivanand Kattimani, et al.
Published: (2013-01-01)

Correlates of alcohol withdrawal
by: Rajmohan Velayudhan
Published: (2013-12-01)

Pulmonologists’ Opinion on the Use of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease Patients in Spain: A Cross-Sectional Survey
by: Miravitlles M, et al.
Published: (2022-07-01)

Glucocorticoid induced adrenal insufficiency in children: Morning cortisol values to avoid LDSST
by: Margaux Laulhé, et al.
Published: (2022-12-01)

End-tidal concentration of sevoflurane for reducing rocuronium-induced withdrawal reactions in adult patients: a comparison between male and female patients
by: Jong Hoon Yeom, et al.
Published: (2014-06-01)

The right of the member to withdraw from limited liability company
by: Г. О. Уразова
Published: (2015-05-01)

Amantadine as Augmentation in Managing Opioid Withdrawal with Clonidine: a randomized controlled trial.
by: Shahrokh Amiri, et al.
Published: (2014-09-01)

The influence of age and gender on remifentanil EC for preventing rocuronium induced withdrawal movements
by: So Jin Park, et al.
Published: (2010-03-01)

Concurrent opioid and alcohol withdrawal management
by: Michelle Colvard, PharmD, BCPP
Published: (2023-12-01)

Relationship between academic staff withdrawal behaviours and administrative effectiveness of heads of department of universities
by: Beauty Avoedoya Azelama, et al.
Published: (2022-03-01)

An evidence-based approach to the post-marketing withdrawal of medicinal products because of adverse reactions
by: Onakpoya, I
Published: (2017)

Trends in pharmacotherapy selection for the treatment of alcohol withdrawal in the Free State Province, South Africa
by: Paulina M van Zyl, et al.
Published: (2013-11-01)

End-tidal concentration of sevoflurane for preventing rocuronium-induced withdrawal of the arm in pediatric patients
by: Jong Hoon Yeom, et al.
Published: (2014-04-01)

Seizures and alcohol withdrawal: A literature review
by: M. Gonçalves, et al.
Published: (2022-06-01)